| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 29.248 | 111.115 | 117.417 | 96.403 | 166.581 |
| Total Income - EUR | - | - | - | - | 0 | 29.249 | 111.123 | 117.421 | 96.484 | 166.795 |
| Total Expenses - EUR | - | - | - | - | 2.960 | 24.644 | 86.590 | 106.275 | 87.937 | 117.360 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.960 | 4.605 | 24.532 | 11.145 | 8.547 | 49.435 |
| Net Profit/Loss - EUR | - | - | - | - | -2.960 | 4.504 | 23.555 | 10.147 | 7.630 | 44.531 |
| Employees | - | - | - | - | 0 | 1 | 3 | 4 | 3 | 3 |
Check the financial reports for the company - Lukass Dalyra Medicales S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 4.697 | 4.986 | 4.781 | 3.953 | 3.101 | 2.821 |
| Current Assets | - | - | - | - | 684 | 8.655 | 23.669 | 32.783 | 23.858 | 52.476 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 4 |
| Receivables | - | - | - | - | 0 | 128 | 2.181 | 4.488 | 10.125 | 9.473 |
| Cash | - | - | - | - | 684 | 8.527 | 21.488 | 28.295 | 13.734 | 42.999 |
| Shareholders Funds | - | - | - | - | -2.918 | 1.642 | 25.160 | 30.316 | 17.729 | 44.580 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 8.298 | 12.132 | 5.286 | 7.954 | 10.320 | 11.301 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lukass Dalyra Medicales S.r.l.